To explain that, two additional assumptions were made and tested: leptin and/or adiponectin could be able to modify, by a systemic effect, angiogenesis events and hyperleptinemia could affect cancer treatment effectiveness in obesity situation. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.